MCV: When red blood cells are too large (and what it has to do with longevity)

Open your latest complete blood count. Look for the line labeled “MCV” or “Mean Corpuscular Volume.” You’ll probably see a number around 85-95, with “fL” as the unit of measurement.

Your doctor didn’t comment on it. The lab reported it as “within normal range.” You never gave it much thought.

Yet that number tells something profound about your health: how large your red blood cells are. And red blood cell size isn’t just a technical detail — it’s an indicator of how your body synthesizes DNA, absorbs vitamins, manages inflammation, and (according to a growing body of research) how fast you’re aging.

MCV is one of the 9 critical biomarkers in PhenoAge — the most validated algorithm for calculating biological age. It’s not an additional test: you already have it in your latest blood work. All you need is someone to explain what those numbers mean.

For a lab-report reference page with ranges, aliases, and SuperAge context, see the MCV biomarker guide.

What you’ll learn:

• What is MCV and what does it actually measure
• Normal values vs. optimal values: the distinction that matters
• High MCV (macrocytosis): causes, mechanisms, and when to worry
• Low MCV (microcytosis): the opposite side
• MCV and longevity: what mortality studies tell us
• MCV and cognitive decline: the connection nobody explained
• How to read MCV and RDW together
• 6 strategies to optimize your MCV
• How SuperAge uses MCV to calculate your biological age
• FAQ

---

What Is MCV?

MCV stands for Mean Corpuscular Volume. It measures the average size of your red blood cells, expressed in femtoliters (fL).

Quick definition: MCV is a complete blood count parameter that indicates the average size of red blood cells. High values mean red blood cells that are too large (macrocytosis). Low values mean red blood cells that are too small (microcytosis). Both conditions signal a problem.

How it’s measured

MCV is automatically calculated by the hematology analyzer during a standard complete blood count (CBC). The formula is simple:

MCV = Hematocrit / Red Blood Cell Count × 10

In practice, if your hematocrit is 42% and you have 4.7 million red blood cells per microliter, your MCV will be about 89 fL. You don’t need to do the math — the lab does it for you.

Why red blood cell size matters

Your red blood cells are biconcave discs about 6-8 micrometers in diameter. This shape and size aren’t random: they’re designed to pass through the narrowest capillaries in the body (some only 3 micrometers wide) and to maximize oxygen exchange surface area.

When red blood cells are too large:

• They struggle to pass through the smallest capillaries — reducing tissue perfusion
• They have a less favorable surface-to-volume ratio — transporting oxygen less efficiently
• They signal a production problem — something has altered maturation in the bone marrow

When they’re too small:

• They contain less hemoglobin — carrying less oxygen per cell
• They indicate iron deficiency or thalassemia — conditions with very different mechanisms

In both cases, the abnormal size is a symptom, not a disease. MCV is a window into the health of your bone marrow, your nutritional status, and your metabolism.

MCV, MCH, and MCHC: the three corpuscular indices

MCV isn’t alone in your blood count. It’s accompanied by two other indices that together tell the complete story:

Index	What it measures	Unit	Normal range
MCV	Average red blood cell size	fL	80-100
MCH	Average hemoglobin content per red blood cell	pg	27-33
MCHC	Average hemoglobin concentration in red blood cell	g/dL	32-36

MCV tells you how large the red blood cell is. MCH tells you how much hemoglobin it contains. MCHC tells you how concentrated the hemoglobin is inside it. Together, they allow precise classification of anemias and guide diagnosis.

---

Normal Values and Optimal Values

The standard reference range for MCV is 80-100 fL. But as with albumin and RDW, there’s an important difference between “normal” and “optimal.”

Classification	MCV (fL)	Meaning
Severe microcytosis	< 70	Severe iron deficiency or thalassemia — requires urgent evaluation
Microcytosis	70-79	Small red blood cells — investigate iron deficiency, thalassemia
Low normal	80-84	Within range, but check serum iron and ferritin
Optimal	85-95	Range associated with the best health and longevity outcomes
High normal	96-100	Within range, but watch if increasing over time
Mild macrocytosis	100-110	Large red blood cells — investigate B12, folate, thyroid, alcohol
Severe macrocytosis	> 110	Almost always pathological — megaloblastic anemia likely

The optimal range for longevity: 85-95 fL

Mortality research suggests that the ideal range for longevity is narrower than the “normal” range. A study of 66,294 subjects in Taiwan demonstrated that MCV ≥ 99 fL is an independent risk factor for cardiovascular and cerebrovascular death — even when the value is technically “within normal range.”

And it’s not just macrocytosis that’s problematic. Even values at the low end (< 82 fL) can indicate subclinical iron deficiency that accelerates cellular aging through oxidative stress.

Key point: Don’t settle for an MCV “within normal range.” Your goal should be to maintain it consistently in the 85-95 fL range — and monitor the trend over time, not just the single value.

How MCV changes with age

MCV tends to increase slightly with aging — about 1 fL per decade after age 50. This increase is considered “physiological,” but it reflects real changes in bone marrow physiology:

• Reduced proliferative capacity of hematopoietic stem cells
• Decreased vitamin B12 absorption (due to reduced gastric intrinsic factor)
• Higher prevalence of chronic low-grade inflammation

Age group	Average MCV	Optimal range for longevity
20-40 years	85-92 fL	85-93 fL
40-60 years	86-94 fL	85-95 fL
60-80 years	88-96 fL	86-95 fL
80+ years	89-98 fL	87-96 fL

Note: Ranges may vary slightly from lab to lab. Always refer to the reference values printed on your report.

---

High MCV (Macrocytosis): Causes, Mechanisms, and When to Worry

Macrocytosis — red blood cells with MCV > 100 fL — affects about 3-4% of the general population, but prevalence rises significantly with age. After 65, an estimated 10% of people have elevated MCV.

Main causes

1. Vitamin B12 deficiency

This is the most common cause of macrocytosis, especially in older adults. Vitamin B12 is essential for DNA synthesis in rapidly dividing cells — like those in bone marrow.

Mechanism: Without sufficient B12, red blood cell precursors can’t complete cell division normally. The cytoplasm matures, but the nucleus lags behind (a condition called nuclear-cytoplasmic asynchrony). The result is cells larger than normal — megaloblasts.

Who’s at higher risk:

• Over 60 (10-30% have subclinical B12 deficiency)
• Strict vegetarians and vegans
• Long-term metformin users
• Those with atrophic gastritis or who’ve had bariatric surgery
• Chronic proton pump inhibitor users (omeprazole, pantoprazole)

Typical MCV: 100-130 fL, often > 110 fL in severe forms

2. Folate deficiency (vitamin B9)

Similar mechanism to B12 deficiency, but different causes. Folate is fundamental for DNA methylation — a process critical both for red blood cell production and for epigenetic regulation of aging.

Who’s at higher risk:

• Diet low in leafy green vegetables
• Pregnancy (requirement doubles)
• Chronic alcoholism (interferes with absorption and metabolism)
• Those taking antiepileptic drugs or methotrexate

3. Chronic alcohol consumption

Alcohol has a direct toxic effect on bone marrow stem cells, independent of B12 or folate deficiency. Just 6-8 weeks of regular consumption exceeding 40 g/day (about 3-4 glasses of wine) can show MCV increase.

Why it matters: MCV is used in forensic medicine and fitness evaluations as a marker of chronic alcohol consumption. Unlike gamma-GT (which can be elevated for many reasons), high MCV in a healthy adult is highly suggestive of alcohol abuse.

Normalization time: After cessation, MCV can take 3-4 months to return to normal (the average lifespan of a red blood cell is 120 days).

4. Hypothyroidism

Thyroid hormones stimulate erythropoietin production and red blood cell maturation. Up to 55% of hypothyroid patients have macrocytosis.

Important connection: Hypothyroidism is often underdiagnosed in older adults, and macrocytosis may be the first clue. If your MCV is elevated and there’s no B12/folate deficiency or alcohol consumption, request a TSH test.

5. Other causes

Cause	Mechanism	Typical MCV
Medications (methotrexate, azathioprine, hydroxyurea)	Interference with DNA synthesis	100-120 fL
Liver diseases (cirrhosis)	Altered lipid metabolism of red blood cell membranes	100-115 fL
Myelodysplastic syndromes	Abnormal bone marrow production	100-130 fL
Reticulocytosis (response to acute hemorrhage)	Reticulocytes are physiologically larger	100-110 fL

When to worry

Not all high MCVs are equal. Here’s a guide to orient yourself:

MCV (fL)	Attention level	Recommended action
100-105	Moderate attention	Test B12, folate, TSH. Evaluate alcohol consumption
105-110	High attention	As above + peripheral blood smear, liver function
> 110	Urgent attention	Almost certainly pathological — consult hematologist. > 115 fL strongly suggestive of megaloblastic anemia

Warning: Elevated MCV without anemia (isolated macrocytosis) is not harmless. It often precedes overt anemia by months or years. Treat it as an early warning signal, not an irrelevant finding.

Associated symptoms

Symptoms of high MCV depend on the underlying cause:

From B12 deficiency:

• Fatigue and weakness
• Tingling and numbness in hands and feet (peripheral neuropathy)
• Difficulty concentrating and memory problems
• Glossitis (red, smooth tongue)
• Pallor

From chronic alcohol:

• Often asymptomatic (MCV rises before symptoms)
• Signs of liver disease in advanced cases

From hypothyroidism:

• Fatigue, weight gain
• Cold intolerance
• Dry skin, brittle hair
• Bradycardia

---

Low MCV (Microcytosis)

Microcytosis — MCV < 80 fL — deserves separate treatment because it has completely different causes and mechanisms from macrocytosis.

The two main causes

1. Iron deficiency

This is the most common cause of anemia worldwide (affecting approximately 2 billion people globally). Iron is essential for hemoglobin synthesis. When it’s scarce, bone marrow produces smaller red blood cells with less hemoglobin.

Who’s at higher risk:

• Women of childbearing age (due to menstruation)
• Pregnant women
• Vegetarians and vegans
• People with occult gastrointestinal losses (ulcers, polyps, celiac disease)
• Frequent blood donors

2. Thalassemia

A group of genetic diseases that alter hemoglobin chain production. Very common in the Mediterranean area (“Mediterranean anemia” is a form of beta-thalassemia).

Key difference from iron deficiency:

• In iron deficiency, ferritin is low and serum iron is low
• In thalassemia, ferritin is normal or high and MCV is disproportionately low relative to the degree of anemia

Practical advice: If your MCV is low (< 80 fL) but ferritin is normal, don’t start blind iron supplementation. It could be thalassemia trait — and excess iron is toxic. Ask your doctor for hemoglobin electrophoresis.

---

MCV and Longevity: What Mortality Studies Tell Us

And here’s where the MCV story becomes truly interesting. Because this “simple” blood count parameter has a surprising correlation with mortality — much stronger than most doctors suspect.

The Taiwanese study: the MCV-mortality gradient

A study of 66,294 subjects in Taiwan demonstrated a dose-response relationship between MCV and mortality:

• MCV ≥ 99 fL: independent risk factor for cardiovascular and cerebrovascular death
• Each 5 fL increase beyond the 95 fL threshold is associated with progressive risk increase
• The association persists even after adjusting for age, sex, BMI, smoking, and other confounders

Wen, 2018 — Gradient Relationship Between Increased MCV and Mortality

MCV and mortality in hemodialysis patients

In a study of hemodialysis patients, MCV > 100 fL was associated with 28% higher all-cause mortality risk compared to normal values, with increases in both cardiovascular and infectious mortality.

Shepshelovich et al., 2019 — Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients

MCV and mortality in the general population

A large study showed that elevated MCV values are associated with all-cause mortality and liver cancer mortality even in non-anemic, apparently healthy subjects. The adjusted hazard ratio for the highest MCV quartiles ranged from 1.44 to 1.55.

Yoon et al., 2015 — Mean corpuscular volume levels and all-cause and liver cancer mortality

MCV and arterial stiffness

A 2020 study found that even “borderline-high” MCV (in the upper normal range) is associated with greater arterial stiffness in apparently healthy individuals — an early marker of vascular aging.

2025–2026: new multicenter evidence reinforces MCV as a mortality biomarker

Three recent studies have strengthened MCV’s role as an independent mortality predictor across very different clinical settings — confirming the signal goes well beyond hematology.

• Chronic kidney disease (ICU patients, 2025). The first multicenter cohort study on this question pooled 23,724 critically ill CKD patients from MIMIC-IV and eICU-CRD. Each unit increase in MCV raised 30-day in-hospital mortality with HR 1.04 (95% CI 1.02–1.05). Patients in the highest MCV stratum had 71% higher 30-day mortality (HR 1.71, 95% CI 1.36–2.16) compared to the lowest, with results persisting at 90 days. The authors propose MCV as a routine, low-cost biomarker for risk stratification in ICU.
• COVID-19 mortality (2025). A prognostic study found that MCV > 89 fL is an independent predictor of death in patients hospitalized for SARS-CoV-2 infection, outperforming several composite inflammatory indices when used as a simple cutoff.
• Non-small cell lung cancer (2026). In surgically treated NSCLC, MCV showed a linear dose-response relationship with mortality independent of conventional prognostic factors — adding to the evidence that even modest MCV elevations carry survival implications.

These three studies converge on the same message: MCV is not a passive bystander. It tracks systemic biology (nutritional reserve, inflammation, marrow function) and that signal translates into hard outcomes across cardiovascular, infectious, and oncologic disease.

The connection to centenarians

The AMORIS study (Swedish Apolipoprotein MOrtality RISk study) followed 1,224 centenarians for 35 years, analyzing their blood profiles from age 65. Results show that those who reach 100 tend to have more homogeneous and moderate biomarker profiles — without extreme values in any direction.

Although MCV wasn’t the primary parameter of the study, the message is clear: stability of blood parameters is a longevity marker. Centenarians don’t have “exceptional” values — they have stable, moderate values, including MCV.

The message for your longevity: An MCV consistently in the 85-95 fL range, year after year, is a signal of good bone marrow homeostasis and adequate nutritional status — two fundamental factors for aging slowly.

---

MCV and Cognitive Decline: The Connection Nobody Explained

One of the most fascinating (and least known) aspects of MCV is its correlation with cognitive function.

The key study

A study published in Age and Ageing examined the relationship between MCV and cognitive performance in adults over 60. Results:

• Participants with MCV ≥ 97 fL showed accelerated cognitive decline compared to those with values ≤ 85 fL
• The association was independent of anemia — even with normal hemoglobin, high MCV correlated with worse cognitive performance
• Two mechanisms hypothesized:
  1. Direct: Red blood cells that are too large struggle to pass through the thinnest cerebral capillaries, compromising neuronal perfusion
  2. Indirect: B12/folate deficiencies that cause macrocytosis also cause homocysteine accumulation — a known neurotoxin

Gamaldo et al., 2013 — The Relationship between Mean Corpuscular Volume and Cognitive Performance in Older Adults

Why this matters to you

Vitamin B12 deficiency is often silent hematologically — hemoglobin levels can remain normal for months or years while neurological damage progresses. MCV can be the first warning bell of a deficiency that’s already damaging your brain.

This is particularly critical after 60, when:

• B12 absorption decreases (due to reduced gastric hydrochloric acid)
• 10-30% of those over 60 have subclinical B12 deficiency
• Neurological symptoms can be wrongly attributed to “aging”

Crucial advice: If you’re over 60 and your MCV is increasing (even if still within normal range), request vitamin B12 and methylmalonic acid (MMA) testing. MMA is a more sensitive marker of B12 deficiency than serum B12 level itself.

---

How to Read MCV and RDW Together

If you’ve read our article on RDW, you already know that this parameter measures the variability of red blood cell sizes. MCV measures average size. Together, they’re much more informative than either one separately.

The MCV/RDW diagnostic matrix

	Normal RDW	High RDW
Low MCV	Thalassemia trait	Iron deficiency
Normal MCV	All good	Mixed deficiency (iron + B12), early stage
High MCV	Alcohol (uniformly high MCV), hypothyroidism	B12/folate deficiency, megaloblastic anemia

This matrix is used daily by hematologists to guide diagnosis. Here’s how to read it:

• Low MCV + normal RDW: Red blood cells are all small but uniform → probably thalassemia (genetic, consistent size)
• Low MCV + high RDW: Red blood cells are small but of variable sizes → iron deficiency (uneven production)
• High MCV + normal RDW: Red blood cells are all large but uniform → direct toxic effect (alcohol) or hypothyroidism
• High MCV + high RDW: Red blood cells are large and of variable sizes → B12/folate deficiency (irregular megaloblastic production)

Why the combination matters for longevity

For PhenoAge — the biological age algorithm used by SuperAge — both MCV and RDW are critical biomarkers. The combination of the two parameters provides a much more complete picture of your bone marrow health and nutritional status than either value in isolation.

The ideal profile for longevity is:

• MCV: 85-95 fL (optimal average size)
• RDW-CV: 11.5-13.0% (high uniformity)

This profile indicates bone marrow functioning efficiently and uniformly — a signal of good homeostasis that translates to lower biological age.

---

6 Strategies to Optimize Your MCV

1. Monitor vitamin B12 (and don’t settle for “normal”)

Standard reference ranges for serum B12 (200-900 pg/mL) are too broad. Values between 200 and 400 pg/mL are “within normal range” but associated with functional deficiency in 5-20% of cases.

Target values:

• Serum B12: > 500 pg/mL (ideally > 600 pg/mL)
• Methylmalonic acid (MMA): < 270 nmol/L (more specific B12 marker)
• Homocysteine: < 12 μmol/L (integrated marker of B12 and folate)

Food sources: Liver (83 μg/100g), clams (98 μg/100g), mackerel (19 μg/100g), eggs (1.1 μg/100g), dairy products.

Supplementation: If needed, prefer methylcobalamin over cyanocobalamin — it’s the bioactive form and doesn’t require liver conversion.

2. Ensure adequate folate intake

Folate (vitamin B9) is the essential cofactor of B12 in DNA synthesis. Folate deficiency causes macrocytosis through an identical mechanism to B12 deficiency.

Target values:

• Serum folate: > 10 ng/mL
• Red blood cell folate: > 400 ng/mL (better marker of long-term status)

Food sources: Spinach (194 μg/100g), asparagus (149 μg/100g), lentils (181 μg/100g cooked), chickpeas (172 μg/100g cooked), broccoli (63 μg/100g).

Supplementation: Prefer 5-MTHF (methylfolate) over synthetic folic acid, especially if you have the MTHFR polymorphism (present in 10-15% of the population).

3. Moderate alcohol consumption

Alcohol is a direct enemy of your MCV — and your biological aging in general.

Evidence-based thresholds:

• < 10 g/day (about 1 glass of wine): minimal impact on MCV
• 20-40 g/day (2-3 glasses): measurable increase after 2-3 months
• > 40 g/day (3+ glasses): macrocytosis likely within 6-8 weeks

If your MCV is elevated and you consume alcohol regularly, a 3-4 month abstinence period is the simplest and most informative test: if MCV drops, you have your answer.

4. Check thyroid function

If your MCV is elevated and B12, folate, and alcohol consumption are normal, the next step is a TSH test. Subclinical hypothyroidism is an underestimated cause of macrocytosis, especially in women over 50.

Target values (for optimal longevity):

• TSH: 1.0-2.5 mIU/L (not just “within range,” which goes up to 4.5)
• fT4: mid-high reference range

5. If MCV is low, investigate iron and ferritin

Don’t take iron blindly. Before supplementing, verify:

Parameter	Iron deficiency	Thalassemia trait
Ferritin	Low (< 30 ng/mL)	Normal or high
Serum iron	Low	Normal
Transferrin	High	Normal
Transferrin saturation	Low (< 20%)	Normal
Hb electrophoresis	Normal	Elevated HbA2

Excess iron is toxic. Supplement only if you have documented deficiency.

6. Monitor the trend, not the single value

A single MCV value says little. What matters is the trend over time:

• MCV rising 2-3 fL per year → possible developing B12 deficiency
• MCV stable year after year in 85-95 fL range → excellent homeostasis indicator
• MCV dropping suddenly → possible acute iron deficiency

Ideally, compare your MCV with values from the last 3-5 years. Many labs keep historical records — request a printout.

---

How SuperAge Uses MCV to Calculate Your Biological Age

MCV is one of the 9 critical biomarkers in PhenoAge — the algorithm developed by Morgan Levine’s lab at Yale School of Medicine and among the most validated worldwide for biological age calculation.

The 9 PhenoAge biomarkers

Biomarker	What it measures	Weight in PhenoAge
Albumin	Nutritional status and liver function	High
Creatinine	Kidney function	Medium
Glucose	Sugar metabolism	Medium
C-reactive protein	Systemic inflammation	High
Lymphocyte %	Immune function	Medium
Mean corpuscular volume (MCV)	Bone marrow health and nutritional status	Medium
RDW	Red blood cell production uniformity	Medium
Alkaline phosphatase	Liver and bone function	Medium
White blood cells	Inflammation and immunity	Medium

How SuperAge integrates MCV

SuperAge automatically recognizes MCV from your blood tests — whether you upload it as a photo, PDF, or digital report. The app:

1. Extracts the value using optical recognition, including common abbreviations (MCV, VCM)
2. Verifies plausibility (accepted range: 50-130 fL; critical range: < 70 or > 120 fL)
3. Combines it with the other 8 PhenoAge biomarkers to calculate your biological age
4. Tracks the trend over time — so you can see if your MCV is improving or worsening

This is the real advantage: you don’t need to be a hematologist to understand if your MCV is where it should be. SuperAge translates that number into concrete information about your aging rate.

Why monitoring MCV makes you younger

MCV is a window into three fundamental aging processes:

1. Nutritional status → B12 and folate are essential for DNA methylation (the heart of the epigenetic clock)
2. Chronic inflammation → Causes of macrocytosis (alcohol, liver diseases) are also drivers of inflammaging
3. Bone marrow efficiency → A marrow that produces uniformly sized red blood cells is a young marrow

Improving MCV isn’t an end in itself. It means you’re correcting nutritional deficiencies, reducing inflammation, and supporting bone marrow function — all factors that slow your biological clock.

---

Frequently Asked Questions

What does high MCV mean in blood tests?

High MCV (> 100 fL) indicates that your red blood cells are larger than average — a condition called macrocytosis. The most common causes are vitamin B12 or folate deficiency, chronic alcohol consumption, hypothyroidism, and certain medications. It’s not a disease itself, but a signal that something has altered red blood cell production in the bone marrow.

When should I worry about high MCV?

If your MCV is between 100 and 105 fL, it’s time to investigate with additional tests (B12, folate, TSH, liver function). Above 110 fL, the cause is almost certainly pathological and requires hematological evaluation. Above 115 fL, megaloblastic anemia is highly likely. Even “borderline-high” MCV (96-100 fL) deserves attention if it’s increasing compared to previous years.

How do you lower high MCV?

It depends on the cause. If due to B12 deficiency, supplementation (methylcobalamin 1000-2000 μg/day or intramuscular injections) normalizes MCV in 2-3 months. If caused by alcohol, 3-4 months of abstinence are needed. If from hypothyroidism, levothyroxine treatment progressively reduces MCV. The key is identifying the cause before treating.

What’s the difference between MCV and RDW?

MCV measures the average size of red blood cells, RDW measures the variability of their sizes. Together they form a powerful diagnostic matrix: for example, low MCV with high RDW suggests iron deficiency, while low MCV with normal RDW suggests thalassemia. Both are critical PhenoAge biomarkers for biological age calculation.

Can MCV really affect aging speed?

Indirectly, yes. Altered MCV (too high or too low) reflects conditions — nutritional deficiencies, chronic inflammation, metabolic dysfunction — that are recognized drivers of biological aging. Studies of tens of thousands of people show that MCV in the optimal range (85-95 fL) is associated with lower mortality and better cognitive function over time. It’s not MCV itself that makes you age — it’s what abnormal MCV reveals about your health.

How much does MCV testing cost?

MCV is included in a standard complete blood count (CBC) — it’s not a separate test. With insurance or national health services, a CBC typically costs $10-30. In private labs, the price is generally between $20 and $50. If you do routine blood work once a year, you already have MCV — just look at the report.

---

Key Takeaways

• MCV measures the average size of your red blood cells — it’s already in your blood count, no additional tests needed
• The optimal range for longevity is 85-95 fL — narrower than the “normal” range of 80-100 fL
• High MCV (> 100 fL) primarily signals B12/folate deficiency, alcohol consumption, or hypothyroidism
• Low MCV (< 80 fL) usually indicates iron deficiency or thalassemia — don’t supplement iron without diagnosis
• MCV predicts all-cause mortality — studies of tens of thousands of people confirm the dose-response gradient
• MCV ≥ 97 fL is associated with accelerated cognitive decline, even without anemia
• MCV + RDW together are much more informative than either single value — use the diagnostic matrix
• MCV is one of 9 PhenoAge biomarkers used by SuperAge to calculate your biological age
• The trend matters more than the single value — compare your MCV from the last 3-5 years

---

Start Monitoring Your MCV Today

MCV is one of those parameters you’ve always had right in front of you without knowing how important it was. Now you know.

You don’t need expensive tests or to go to specialized centers. Just take your latest blood count, look at the MCV value, and ask yourself: Is it stable compared to last year? Is it in the optimal range for longevity?

If you want to make this process automatic — and see how MCV integrates with the other 8 PhenoAge biomarkers to calculate your biological age — download SuperAge and upload your blood tests. In seconds you’ll have a complete picture of your aging rate.

---

References

1. Wen, 2018 — Gradient Relationship Between Increased Mean Corpuscular Volume and Mortality — Study of 66,294 subjects: MCV ≥ 99 fL is independent risk factor for cardiovascular and cerebrovascular mortality.
2. Shepshelovich et al., 2019 — Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients — MCV > 100 fL associated with +28% mortality risk.
3. Yoon et al., 2015 — Mean corpuscular volume levels and all-cause and liver cancer mortality — Elevated MCV predicts mortality even in non-anemic subjects.
4. Gamaldo et al., 2013 — The Relationship between Mean Corpuscular Volume and Cognitive Performance — MCV ≥ 97 fL correlated with accelerated cognitive decline.
5. Levine et al., 2018 — An epigenetic biomarker of aging (PhenoAge) — MCV is one of 9 biomarkers in the PhenoAge algorithm.
6. Mulet-Margalef et al., 2023 — Blood biomarker profiles and exceptional longevity (AMORIS cohort) — Swedish study of 1,224 centenarians: moderate and stable biomarker profiles.
7. Cao et al., 2025 — Association between mean corpuscular volume and mortality in chronic kidney disease ICU patients — Multicenter cohort of 23,724 patients: HR 1.71 (highest vs lowest tertile) for 30-day mortality.
8. The mean corpuscular volume (MCV) is a hematological biomarker associated with COVID-19 mortality risk, 2025 — MCV > 89 fL is independent mortality predictor in SARS-CoV-2 infection.
9. Mean Corpuscular Volume as a Prognostic Marker in Patients with Non-Small Cell Lung Cancer Undergoing Surgical Resection, 2026 — Dose-response relationship between MCV and mortality in resected NSCLC.

---

Last updated: 2026-06-17. This article is regularly reviewed for accuracy. The information provided does not replace professional medical advice.